{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T15:28:43Z","timestamp":1791300523967,"version":"4.1.0"},"reference-count":106,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2015,1,13]],"date-time":"2015-01-13T00:00:00Z","timestamp":1421107200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Neuropathol"],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1007\/s00401-015-1384-5","type":"journal-article","created":{"date-parts":[[2015,1,12]],"date-time":"2015-01-12T06:35:31Z","timestamp":1421044531000},"page":"611-624","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":126,"title":["Amyloid deposits and inflammatory infiltrates in sporadic inclusion body myositis: the inflammatory egg comes before the degenerative chicken"],"prefix":"10.1007","volume":"129","author":[{"given":"Olivier","family":"Benveniste","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Werner","family":"Stenzel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Hilton-Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Sandri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Boyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baziel G. M.","family":"van Engelen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,1,13]]},"reference":[{"issue":"3","key":"1384_CR1","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/s00401-009-0554-8","volume":"118","author":"WF Abdo","year":"2009","unstructured":"Abdo WF, van Mierlo T, Hengstman GJ, Schelhaas HJ, van Engelen BG, Verbeek MM (2009) Increased plasma amyloid-beta42 protein in sporadic inclusion body myositis. Acta Neuropathol 118(3):429\u2013431","journal-title":"Acta Neuropathol"},{"issue":"3","key":"1384_CR2","doi-asserted-by":"crossref","first-page":"e88788","DOI":"10.1371\/journal.pone.0088788","volume":"9","author":"WJ Allenbach","year":"2014","unstructured":"Allenbach WJ, Chaara W, Rosenzwajg M, Six A, Prevel N, Mingozzi F, Wanschitz J, Benveniste O (2014) Th1 response and systemic Treg deficiency in inclusion body myositis. PLoS One 9(3):e88788","journal-title":"PLoS One"},{"issue":"3","key":"1384_CR3","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1212\/WNL.61.3.288","volume":"61","author":"AA Amato","year":"2003","unstructured":"Amato AA, Griggs RC (2003) Unicorns, dragons, polymyositis, and other mythological beasts. Neurology 61(3):288\u2013289","journal-title":"Neurology"},{"issue":"Pt 10","key":"1384_CR4","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1093\/brain\/123.10.2030","volume":"123","author":"K Amemiya","year":"2000","unstructured":"Amemiya K, Granger RP, Dalakas MC (2000) Clonal restriction of T-cell receptor expression by infiltrating lymphocytes in inclusion body myositis persists over time. Studies in repeated muscle biopsies. Brain 123(Pt 10):2030\u20132039","journal-title":"Brain"},{"issue":"5","key":"1384_CR5","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.nmd.2005.01.012","volume":"15","author":"R Amouri","year":"2005","unstructured":"Amouri R, Driss A, Murayama K, Kefi M, Nishino I, Hentati F (2005) Allelic heterogeneity of GNE gene mutation in two Tunisian families with autosomal recessive inclusion body myopathy. Neuromuscul Disord NMD 15(5):361\u2013363","journal-title":"Neuromuscul Disord NMD"},{"issue":"8425","key":"1384_CR6","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S0140-6736(85)91384-4","volume":"1","author":"ST Appleyard","year":"1985","unstructured":"Appleyard ST, Dunn MJ, Dubowitz V, Rose ML (1985) Increased expression of HLA ABC class I antigens by muscle fibres in Duchenne muscular dystrophy, inflammatory myopathy, and other neuromuscular disorders. Lancet 1(8425):361\u2013363","journal-title":"Lancet"},{"issue":"2","key":"1384_CR7","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1002\/ana.410160206","volume":"16","author":"K Arahata","year":"1984","unstructured":"Arahata K, Engel AG (1984) Monoclonal antibody analysis of mononuclear cells in myopathies. I: quantitation of subsets according to diagnosis and sites of accumulation and demonstration and counts of muscle fibers invaded by T cells. Ann Neurol 16(2):193\u2013208","journal-title":"Ann Neurol"},{"issue":"4 Pt 2","key":"1384_CR8","first-page":"e219","volume":"40","author":"V Askanas","year":"2011","unstructured":"Askanas V, Engel WK (2011) Sporadic inclusion-body myositis: conformational multifactorial ageing-related degenerative muscle disease associated with proteasomal and lysosomal inhibition, endoplasmic reticulum stress, and accumulation of amyloid-\u03b242 oligomers and phosphorylated tau. Presse M\u00e9dicale Paris Fr 1983 40(4 Pt 2):e219\u2013e235","journal-title":"Presse M\u00e9dicale Paris Fr 1983"},{"issue":"1","key":"1384_CR9","first-page":"31","volume":"141","author":"V Askanas","year":"1992","unstructured":"Askanas V, Engel WK, Alvarez RB (1992) Light and electron microscopic localization of beta-amyloid protein in muscle biopsies of patients with inclusion-body myositis. Am J Pathol 141(1):31\u201336","journal-title":"Am J Pathol"},{"issue":"8792","key":"1384_CR10","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/0140-6736(92)90388-J","volume":"339","author":"V Askanas","year":"1992","unstructured":"Askanas V, Engel WK, Alvarez RB, Glenner GG (1992) Beta-Amyloid protein immunoreactivity in muscle of patients with inclusion-body myositis. Lancet 339(8792):560\u2013561","journal-title":"Lancet"},{"issue":"1","key":"1384_CR11","first-page":"177","volume":"144","author":"V Askanas","year":"1994","unstructured":"Askanas V, Engel WK, Bilak M, Alvarez RB, Selkoe DJ (1994) Twisted tubulofilaments of inclusion body myositis muscle resemble paired helical filaments of Alzheimer brain and contain hyperphosphorylated tau. Am J Pathol 144(1):177\u2013187","journal-title":"Am J Pathol"},{"key":"1384_CR12","author":"V Askanas","year":"2014","unstructured":"Askanas V, Engel WK, Nogalska A (2014) Sporadic inclusion-body myositis: a degenerative muscle disease associated with aging, impaired muscle protein homeostasis and abnormal mitophagy. Biochim Biophys Acta. doi: 10.1016\/j.bbadis.2014.09.005","journal-title":"Biochim Biophys Acta"},{"issue":"9","key":"1384_CR13","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1212\/WNL.55.9.1385","volume":"55","author":"UA Badrising","year":"2000","unstructured":"Badrising UA, Maat-Schieman M, van Duinen SG et al (2000) Epidemiology of inclusion body myositis in The Netherlands: a nationwide study. Neurology 55(9):1385\u20131387","journal-title":"Neurology"},{"issue":"3","key":"1384_CR14","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1002\/ana.10121","volume":"51","author":"UA Badrising","year":"2002","unstructured":"Badrising UA, Maat-Schieman ML, Ferrari MD et al (2002) Comparison of weakness progression in inclusion body myositis during treatment with methotrexate or placebo. Ann Neurol 51(3):369\u2013372","journal-title":"Ann Neurol"},{"issue":"12","key":"1384_CR15","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.1212\/01.WNL.0000148588.15052.4C","volume":"63","author":"UA Badrising","year":"2004","unstructured":"Badrising UA, Schreuder GM, Giphart MJ et al (2004) Associations with autoimmune disorders and HLA class I and II antigens in inclusion body myositis. Neurology 63(12):2396\u20132398","journal-title":"Neurology"},{"issue":"9\u201310","key":"1384_CR16","doi-asserted-by":"crossref","first-page":"875","DOI":"10.2119\/molmed.2011.00084","volume":"17","author":"F Barth\u00e9l\u00e9my","year":"2011","unstructured":"Barth\u00e9l\u00e9my F, Wein N, Krahn M, L\u00e9vy N, Bartoli M (2011) Translational research and therapeutic perspectives in dysferlinopathies. Mol Med Camb Mass 17(9\u201310):875\u2013882","journal-title":"Mol Med Camb Mass"},{"issue":"Pt 11","key":"1384_CR17","doi-asserted-by":"crossref","first-page":"3176","DOI":"10.1093\/brain\/awr213","volume":"134","author":"O Benveniste","year":"2011","unstructured":"Benveniste O, Guiguet M, Freebody J et al (2011) Long-term observational study of sporadic inclusion body myositis. Brain 134(Pt 11):3176\u20133184","journal-title":"Brain"},{"issue":"6","key":"1384_CR18","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1002\/ana.20293","volume":"56","author":"O Benveniste","year":"2004","unstructured":"Benveniste O, Herson S, Salomon B, Dimitri D, Trebeden-Negre H, Jean L, Bon-Durand V, Antonelli D, Klatzmann D, Boyer O (2004) Long-term persistence of clonally expanded T cells in patients with polymyositis. Ann Neurol 56(6):867\u2013872","journal-title":"Ann Neurol"},{"issue":"6","key":"1384_CR19","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.nmd.2010.03.014","volume":"20","author":"O Benveniste","year":"2010","unstructured":"Benveniste O, Hilton-Jones D (2010) International Workshop on Inclusion Body Myositis held at the Institute of Myology, Paris, on 29 May 2009. Neuromuscul Disord 20(6):414\u2013421","journal-title":"Neuromuscul Disord"},{"issue":"9","key":"1384_CR20","doi-asserted-by":"crossref","first-page":"3428","DOI":"10.1182\/blood-2003-07-2598","volume":"103","author":"O Boyer","year":"2004","unstructured":"Boyer O, Saadoun D, Abriol J, Dodille M, Piette J-C, Cacoub P, Klatzmann D (2004) CD4+CD25+ regulatory T-cell deficiency in patients with hepatitis C-mixed cryoglobulinemia vasculitis. Blood 103(9):3428\u20133430","journal-title":"Blood"},{"issue":"11","key":"1384_CR21","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1136\/jnnp-2013-305690","volume":"84","author":"S Brady","year":"2013","unstructured":"Brady S, Squier W, Hilton-Jones D (2013) Clinical assessment determines the diagnosis of inclusion body myositis independently of pathological features. J Neurol Neurosurg Psychiatry 84(11):1240\u20131246","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"4","key":"1384_CR22","doi-asserted-by":"crossref","first-page":"e004552","DOI":"10.1136\/bmjopen-2013-004552","volume":"4","author":"S Brady","year":"2014","unstructured":"Brady S, Squier W, Sewry C, Hanna M, Hilton-Jones D, Holton JL (2014) A retrospective cohort study identifying the principal pathological features useful in the diagnosis of inclusion body myositis. BMJ Open 4(4):e004552","journal-title":"BMJ Open"},{"issue":"5","key":"1384_CR23","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1007\/s00401-013-1186-6","volume":"126","author":"M Cacciottolo","year":"2013","unstructured":"Cacciottolo M, Nogalska A, D\u2019Agostino C, Engel WK, Askanas V (2013) Dysferlin is a newly identified binding partner of A\u03b2PP and it co-aggregates with amyloid-\u03b242 within sporadic inclusion-body myositis (s-IBM) muscle fibers. Acta Neuropathol (Berl) 126(5):781\u2013783","journal-title":"Acta Neuropathol (Berl)"},{"issue":"6","key":"1384_CR24","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1212\/01.wnl.0000277527.69388.fe","volume":"70","author":"N Chahin","year":"2008","unstructured":"Chahin N, Engel AG (2008) Correlation of muscle biopsy, clinical course, and outcome in PM and sporadic IBM. Neurology 70(6):418\u2013424","journal-title":"Neurology"},{"key":"1384_CR25","author":"A Cho","year":"2013","unstructured":"Cho A, Hayashi YK, Monma K, Oya Y, Noguchi S, Nonaka I, Nishino I (2013) Mutation profile of the GNE gene in Japanese patients with distal myopathy with rimmed vacuoles (GNE myopathy). J Neurol Neurosurg Psychiatry. doi: 10.1136\/jnnp-2013-305587","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"Pt 11","key":"1384_CR26","doi-asserted-by":"crossref","first-page":"3167","DOI":"10.1093\/brain\/awr217","volume":"134","author":"FM Cox","year":"2011","unstructured":"Cox FM, Titulaer MJ, Sont JK, Wintzen AR, Verschuuren JJGM, Badrising UA (2011) A 12-year follow-up in sporadic inclusion body myositis: an end stage with major disabilities. Brain J Neurol 134(Pt 11):3167\u20133175","journal-title":"Brain J Neurol"},{"issue":"21","key":"1384_CR27","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1056\/NEJM199111213252107","volume":"325","author":"MC Dalakas","year":"1991","unstructured":"Dalakas MC (1991) Polymyositis, dermatomyositis and inclusion-body myositis. N Engl J Med 325(21):1487\u20131498","journal-title":"N Engl J Med"},{"issue":"3","key":"1384_CR28","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1212\/WNL.56.3.323","volume":"56","author":"MC Dalakas","year":"2001","unstructured":"Dalakas MC, Koffman B, Fujii M, Spector S, Sivakumar K, Cupler E (2001) A controlled study of intravenous immunoglobulin combined with prednisone in the treatment of IBM. Neurology 56(3):323\u2013327","journal-title":"Neurology"},{"issue":"Pt 6","key":"1384_CR29","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1093\/brain\/awp104","volume":"132","author":"MC Dalakas","year":"2009","unstructured":"Dalakas MC, Rakocevic G, Schmidt J et al (2009) Effect of Alemtuzumab (CAMPATH 1-H) in patients with inclusion-body myositis. Brain 132(Pt 6):1536\u20131544","journal-title":"Brain"},{"issue":"3","key":"1384_CR30","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1212\/WNL.48.3.712","volume":"48","author":"MC Dalakas","year":"1997","unstructured":"Dalakas MC, Sonies B, Dambrosia J, Sekul E, Cupler E, Sivakumar K (1997) Treatment of inclusion-body myositis with IVIg: a double-blind, placebo-controlled study. Neurology 48(3):712\u2013716","journal-title":"Neurology"},{"issue":"Pt 4","key":"1384_CR31","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1093\/brain\/awl020","volume":"129","author":"D Dimitri","year":"2006","unstructured":"Dimitri D, Benveniste O, Dubourg O et al (2006) Shared blood and muscle CD8+ T-cell expansions in inclusion body myositis. Brain 129(Pt 4):986\u2013995","journal-title":"Brain"},{"issue":"2","key":"1384_CR32","first-page":"103","volume":"30","author":"O Dubourg","year":"2011","unstructured":"Dubourg O, Wanschitz J, Maisonobe T, B\u00e9hin A, Allenbach Y, Herson S, Benveniste O (2011) Diagnostic value of markers of muscle degeneration in sporadic inclusion body myositis. Acta Myol Myopathies Cardiomyopathies Off J Mediterr Soc Myol Ed Gaetano Conte Acad Study Striated Muscle Dis 30(2):103\u2013108","journal-title":"Acta Myol Myopathies Cardiomyopathies Off J Mediterr Soc Myol Ed Gaetano Conte Acad Study Striated Muscle Dis"},{"issue":"3","key":"1384_CR33","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/0046-8177(89)90128-7","volume":"20","author":"AM Emslie-Smith","year":"1989","unstructured":"Emslie-Smith AM, Arahata K, Engel AG (1989) Major histocompatibility complex class I antigen expression, immunolocalization of interferon subtypes, and T cell-mediated cytotoxicity in myopathies. Hum Pathol 20(3):224\u2013231","journal-title":"Hum Pathol"},{"key":"1384_CR34","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/1471-2377-13-24","volume":"13","author":"C Fischer","year":"2013","unstructured":"Fischer C, Kleinschnitz K, Wrede A, Muth I, Kruse N, Nishino I, Schmidt J (2013) Cell stress molecules in the skeletal muscle of GNE myopathy. BMC Neurol 13:24","journal-title":"BMC Neurol"},{"issue":"2","key":"1384_CR35","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S0002-9440(10)62994-X","volume":"167","author":"P Fratta","year":"2005","unstructured":"Fratta P, Engel WK, McFerrin J, Davies KJ, Lin SW, Askanas V (2005) Proteasome inhibition and aggresome formation in sporadic inclusion-body myositis and in amyloid-beta precursor protein-overexpressing cultured human muscle fibers. Am J Pathol 167(2):517\u2013526","journal-title":"Am J Pathol"},{"issue":"3","key":"1384_CR36","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/j.ajpath.2013.06.003","volume":"183","author":"M Fr\u00e9ret","year":"2013","unstructured":"Fr\u00e9ret M, Drouot L, Obry A, Ahmed-Lacheheb S, Dauly C, Adriouch S, Cosette P, Authier F-J, Boyer O (2013) Overexpression of MHC class I in muscle of lymphocyte-deficient mice causes a severe myopathy with induction of the unfolded protein response. Am J Pathol 183(3):893\u2013904","journal-title":"Am J Pathol"},{"issue":"6968","key":"1384_CR37","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1038\/nature02263","volume":"426","author":"AL Goldberg","year":"2003","unstructured":"Goldberg AL (2003) Protein degradation and protection against misfolded or damaged proteins. Nature 426(6968):895\u2013899","journal-title":"Nature"},{"issue":"7","key":"1384_CR38","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1172\/JCI38027","volume":"119","author":"LG Goldfarb","year":"2009","unstructured":"Goldfarb LG, Dalakas MC (2009) Tragedy in a heartbeat: malfunctioning desmin causes skeletal and cardiac muscle disease. J Clin Invest 119(7):1806\u20131813","journal-title":"J Clin Invest"},{"issue":"1","key":"1384_CR39","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s11910-009-0013-x","volume":"9","author":"SA Greenberg","year":"2009","unstructured":"Greenberg SA (2009) Inclusion body myositis: review of recent literature. Curr Neurol Neurosci Rep 9(1):83\u201389","journal-title":"Curr Neurol Neurosci Rep"},{"issue":"Pt 5","key":"1384_CR40","first-page":"e135","volume":"133","author":"SA Greenberg","year":"2009","unstructured":"Greenberg SA (2009) Comment on alemtuzumab and inclusion body myositis. Brain 133(Pt 5):e135 (author reply e136)","journal-title":"Brain"},{"issue":"11","key":"1384_CR41","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1212\/01.wnl.0000187124.92826.20","volume":"65","author":"SA Greenberg","year":"2005","unstructured":"Greenberg SA, Bradshaw EM, Pinkus JL, Pinkus GS, Burleson T, Due B, Bregoli L, Bregoli LS, O\u2019Connor KC, Amato AA (2005) Plasma cells in muscle in inclusion body myositis and polymyositis. Neurology 65(11):1782\u20131787","journal-title":"Neurology"},{"issue":"5","key":"1384_CR42","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1002\/ana.410380504","volume":"38","author":"RC Griggs","year":"1995","unstructured":"Griggs RC, Askanas V, DiMauro S, Engel A, Karpati G, Mendell JR, Rowland LP (1995) Inclusion body myositis and myopathies. Ann Neurol 38(5):705\u2013713","journal-title":"Ann Neurol"},{"issue":"9","key":"1384_CR43","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1212\/WNL.57.9.1566","volume":"57","author":"Group MS","year":"2001","unstructured":"Group MS (2001) Randomized pilot trial of betaINF1a (Avonex) in patients with inclusion body myositis. Neurology 57(9):1566\u20131570","journal-title":"Neurology"},{"issue":"4","key":"1384_CR44","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1212\/01.WNL.0000134675.98525.79","volume":"63","author":"Group MS","year":"2004","unstructured":"Group MS (2004) Randomized pilot trial of high-dose betaINF-1a in patients with inclusion body myositis. Neurology 63(4):718\u2013720","journal-title":"Neurology"},{"key":"1384_CR45","author":"J-Y Hogrel","year":"2014","unstructured":"Hogrel J-Y, Allenbach Y, Canal A, Leroux G, Ollivier G, Mariampillai K, Servais L, Herson S, Decostre V, Benveniste O (2014) Four-year longitudinal study of clinical and functional endpoints in sporadic inclusion body myositis: Implications for therapeutic trials. Neuromuscul Disord NMD. doi: 10.1016\/j.nmd.2014.04.009","journal-title":"Neuromuscul Disord NMD"},{"issue":"5","key":"1384_CR46","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1002\/ana.410290509","volume":"29","author":"R Hohlfeld","year":"1991","unstructured":"Hohlfeld R, Engel AG (1991) Coculture with autologous myotubes of cytotoxic T cells isolated from muscle in inflammatory myopathies. Ann Neurol 29(5):498\u2013507","journal-title":"Ann Neurol"},{"issue":"3","key":"1384_CR47","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1016\/j.ajpath.2011.05.055","volume":"179","author":"J Ivanidze","year":"2011","unstructured":"Ivanidze J, Hoffmann R, Lochmuller H, Engel AG, Hohlfeld R, Dornmair K (2011) Inclusion body myositis: laser microdissection reveals differential up-regulation of IFN-gamma signaling cascade in attacked versus nonattacked myofibers. Am J Pathol 179(3):1347\u20131359","journal-title":"Am J Pathol"},{"issue":"6","key":"1384_CR48","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1083\/jcb.200908115","volume":"187","author":"J-S Ju","year":"2009","unstructured":"Ju J-S, Fuentealba RA, Miller SE, Jackson E, Piwnica-Worms D, Baloh RH, Weihl CC (2009) Valosin-containing protein (VCP) is required for autophagy and is disrupted in VCP disease. J Cell Biol 187(6):875\u2013888","journal-title":"J Cell Biol"},{"issue":"2","key":"1384_CR49","doi-asserted-by":"crossref","first-page":"283","DOI":"10.4161\/auto.6.2.11063","volume":"6","author":"J-S Ju","year":"2010","unstructured":"Ju J-S, Weihl CC (2010) p97\/VCP at the intersection of the autophagy and the ubiquitin proteasome system. Autophagy 6(2):283\u2013285","journal-title":"Autophagy"},{"issue":"6","key":"1384_CR50","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.2353\/ajpath.2006.051232","volume":"168","author":"M Kitazawa","year":"2006","unstructured":"Kitazawa M, Green KN, Caccamo A, LaFerla FM (2006) Genetically augmenting Abeta42 levels in skeletal muscle exacerbates inclusion body myositis-like pathology and motor deficits in transgenic mice. Am J Pathol 168(6):1986\u20131997","journal-title":"Am J Pathol"},{"issue":"1","key":"1384_CR51","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/ana.21325","volume":"64","author":"M Kitazawa","year":"2008","unstructured":"Kitazawa M, Trinh DN, LaFerla FM (2008) Inflammation induces tau pathology in inclusion body myositis model via glycogen synthase kinase-3beta. Ann Neurol 64(1):15\u201324","journal-title":"Ann Neurol"},{"issue":"5","key":"1384_CR52","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1002\/cbic.201200731","volume":"14","author":"T Klingstedt","year":"2013","unstructured":"Klingstedt T, Blechschmidt C, Nogalska A, Prokop S, H\u00e4ggqvist B, Danielsson O, Engel WK, Askanas V, Heppner FL, Nilsson KPR (2013) Luminescent conjugated oligothiophenes for sensitive fluorescent assignment of protein inclusion bodies. Chembiochem Eur J Chem Biol 14(5):607\u2013616","journal-title":"Chembiochem Eur J Chem Biol"},{"issue":"2","key":"1384_CR53","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0165-5728(97)00245-2","volume":"84","author":"BM Koffman","year":"1998","unstructured":"Koffman BM, Sivakumar K, Simonis T, Stroncek D, Dalakas MC (1998) HLA allele distribution distinguishes sporadic inclusion body myositis from hereditary inclusion body myopathies. J Neuroimmunol 84(2):139\u2013142","journal-title":"J Neuroimmunol"},{"issue":"10","key":"1384_CR54","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/S0960-8966(03)00140-8","volume":"13","author":"S Krause","year":"2003","unstructured":"Krause S, Schlotter-Weigel B, Walter MC, Najmabadi H, Wiendl H, Muller-Hocker J, Muller-Felber W, Pongratz D, Lochmuller H (2003) A novel homozygous missense mutation in the GNE gene of a patient with quadriceps-sparing hereditary inclusion body myopathy associated with muscle inflammation. Neuromuscul Disord 13(10):830\u2013834","journal-title":"Neuromuscul Disord"},{"issue":"1","key":"1384_CR55","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1084\/jem.20061852","volume":"204","author":"K Lahl","year":"2007","unstructured":"Lahl K, Loddenkemper C, Drouin C, Freyer J, Arnason J, Eberl G, Hamann A, Wagner H, Huehn J, Sparwasser T (2007) Selective depletion of Foxp3+ regulatory T cells induces a scurfy-like disease. J Exp Med 204(1):57\u201363","journal-title":"J Exp Med"},{"issue":"3","key":"1384_CR56","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1002\/ana.23840","volume":"73","author":"HB Larman","year":"2013","unstructured":"Larman HB, Salajegheh M, Nazareno R et al (2013) Cytosolic 5\u2032-nucleotidase 1A autoimmunity in sporadic inclusion body myositis. Ann Neurol 73(3):408\u2013418","journal-title":"Ann Neurol"},{"issue":"4","key":"1384_CR57","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1097\/00005792-199307000-00002","volume":"72","author":"RL Leff","year":"1993","unstructured":"Leff RL, Miller FW, Hicks J, Fraser DD, Plotz PH (1993) The treatment of inclusion body myositis: a retrospective review and a randomized, prospective trial of immunosuppressive therapy. Med Baltim 72(4):225\u2013235","journal-title":"Med Baltim"},{"issue":"2","key":"1384_CR58","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1212\/01.WNL.0000071852.27182.C7","volume":"61","author":"C Lindberg","year":"2003","unstructured":"Lindberg C, Trysberg E, Tarkowski A, Oldfors A (2003) Anti-T-lymphocyte globulin treatment in inclusion body myositis: a randomized pilot study. Neurology 61(2):260\u2013262","journal-title":"Neurology"},{"issue":"5","key":"1384_CR59","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1212\/WNL.0000000000000642","volume":"83","author":"TE Lloyd","year":"2014","unstructured":"Lloyd TE, Mammen AL, Amato AA, Weiss MD, Needham M, Greenberg SA (2014) Evaluation and construction of diagnostic criteria for inclusion body myositis. Neurology 83(5):426\u2013433","journal-title":"Neurology"},{"issue":"5","key":"1384_CR60","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1002\/ana.21115","volume":"61","author":"JD Lunemann","year":"2007","unstructured":"Lunemann JD, Schmidt J, Schmid D, Barthel K, Wrede A, Dalakas MC, Munz C (2007) Beta-amyloid is a substrate of autophagy in sporadic inclusion body myositis. Ann Neurol 61(5):476\u2013483","journal-title":"Ann Neurol"},{"issue":"6","key":"1384_CR61","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1038\/nm.1956","volume":"15","author":"MCV Malicdan","year":"2009","unstructured":"Malicdan MCV, Noguchi S, Hayashi YK, Nonaka I, Nishino I (2009) Prophylactic treatment with sialic acid metabolites precludes the development of the myopathic phenotype in the DMRV-hIBM mouse model. Nat Med 15(6):690\u2013695","journal-title":"Nat Med"},{"issue":"12","key":"1384_CR62","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1001\/archneur.1991.00530240033013","volume":"48","author":"JR Mendell","year":"1991","unstructured":"Mendell JR, Sahenk Z, Gales T, Paul L (1991) Amyloid filaments in inclusion body myositis. Novel findings provide insight into nature of filaments. Arch Neurol 48(12):1229\u20131234","journal-title":"Arch Neurol"},{"issue":"3","key":"1384_CR63","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1212\/WNL.61.3.316","volume":"61","author":"MF Meulen Van der","year":"2003","unstructured":"Van der Meulen MF, Bronner IM, Hoogendijk JE, Burger H, van Venrooij WJ, Voskuyl AE, Dinant HJ, Linssen WH, Wokke JH, de Visser M (2003) Polymyositis: an overdiagnosed entity. Neurology 61(3):316\u2013321","journal-title":"Neurology"},{"issue":"4","key":"1384_CR64","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1016\/j.ajpath.2011.12.027","volume":"180","author":"R Morosetti","year":"2012","unstructured":"Morosetti R, Gliubizzi C, Sancricca C, Broccolini A, Gidaro T, Lucchini M, Mirabella M (2012) TWEAK in inclusion-body myositis muscle: possible pathogenic role of a cytokine inhibiting myogenesis. Am J Pathol 180(4):1603\u20131613","journal-title":"Am J Pathol"},{"issue":"6","key":"1384_CR65","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1002\/art.21103","volume":"52","author":"K Nagaraju","year":"2005","unstructured":"Nagaraju K, Casciola-Rosen L, Lundberg I et al (2005) Activation of the endoplasmic reticulum stress response in autoimmune myositis: potential role in muscle fiber damage and dysfunction. Arthritis Rheum 52(6):1824\u20131835","journal-title":"Arthritis Rheum"},{"issue":"16","key":"1384_CR66","doi-asserted-by":"crossref","first-page":"9209","DOI":"10.1073\/pnas.97.16.9209","volume":"97","author":"K Nagaraju","year":"2000","unstructured":"Nagaraju K, Raben N, Loeffler L et al (2000) Conditional up-regulation of MHC class I in skeletal muscle leads to self-sustaining autoimmune myositis and myositis-specific autoantibodies. Proc Natl Acad Sci USA 97(16):9209\u20139214","journal-title":"Proc Natl Acad Sci USA"},{"issue":"3","key":"1384_CR67","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.2353\/ajpath.2010.100050","volume":"177","author":"A Nogalska","year":"2010","unstructured":"Nogalska A, D\u2019Agostino C, Terracciano C, Engel WK, Askanas V (2010) Impaired autophagy in sporadic inclusion-body myositis and in endoplasmic reticulum stress-provoked cultured human muscle fibers. Am J Pathol 177(3):1377\u20131387","journal-title":"Am J Pathol"},{"issue":"3","key":"1384_CR68","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/s00401-009-0564-6","volume":"118","author":"A Nogalska","year":"2009","unstructured":"Nogalska A, Terracciano C, D\u2019Agostino C, King Engel W, Askanas V (2009) p62\/SQSTM1 is overexpressed and prominently accumulated in inclusions of sporadic inclusion-body myositis muscle fibers, and can help differentiating it from polymyositis and dermatomyositis. Acta Neuropathol 118(3):407\u2013413","journal-title":"Acta Neuropathol"},{"issue":"1","key":"1384_CR69","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/j.1365-2990.2007.00864.x","volume":"34","author":"M Oliv\u00e9","year":"2008","unstructured":"Oliv\u00e9 M, van Leeuwen FW, Janu\u00e9 A, Moreno D, Torrej\u00f3n-Escribano B, Ferrer I (2008) Expression of mutant ubiquitin (UBB\u00a0+\u00a01) and p62 in myotilinopathies and desminopathies. Neuropathol Appl Neurobiol 34(1):76\u201387","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"6","key":"1384_CR70","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1097\/BOR.0b013e3283317b31","volume":"21","author":"B Paepe De","year":"2009","unstructured":"De Paepe B, Creus KK, De Bleecker JL (2009) Role of cytokines and chemokines in idiopathic inflammatory myopathies. Curr Opin Rheumatol 21(6):610\u2013616","journal-title":"Curr Opin Rheumatol"},{"issue":"27","key":"1384_CR71","doi-asserted-by":"crossref","first-page":"11125","DOI":"10.1073\/pnas.0811753106","volume":"106","author":"LJ Page","year":"2009","unstructured":"Page LJ, Suk JY, Bazhenova L et al (2009) Secretion of amyloidogenic gelsolin progressively compromises protein homeostasis leading to the intracellular aggregation of proteins. Proc Natl Acad Sci USA 106(27):11125\u201311130","journal-title":"Proc Natl Acad Sci USA"},{"issue":"11","key":"1384_CR72","doi-asserted-by":"crossref","first-page":"3457","DOI":"10.1002\/art.27665","volume":"62","author":"JM Pandya","year":"2010","unstructured":"Pandya JM, Fasth AE, Zong M, Arnardottir S, Dani L, Lindroos E, Malmstrom V, Lundberg IE (2010) Expanded T cell receptor Vbeta-restricted T cells from patients with sporadic inclusion body myositis are proinflammatory and cytotoxic CD28null T cells. Arthritis Rheum 62(11):3457\u20133466","journal-title":"Arthritis Rheum"},{"issue":"6","key":"1384_CR73","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1002\/mus.21230","volume":"39","author":"KC Parker","year":"2009","unstructured":"Parker KC, Kong SW, Walsh RJ et al (2009) Fast-twitch sarcomeric and glycolytic enzyme protein loss in inclusion body myositis. Muscle Nerve 39(6):739\u2013753","journal-title":"Muscle Nerve"},{"issue":"1","key":"1384_CR74","first-page":"136","volume":"75","author":"J Pas Van der","year":"2004","unstructured":"Van der Pas J, Hengstman GJD, ter Laak HJ, Borm GF, van Engelen BGM (2004) Diagnostic value of MHC class I staining in idiopathic inflammatory myopathies. J Neurol Neurosurg Psychiatry 75(1):136\u2013139","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"6","key":"1384_CR75","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1097\/BOR.0b013e32834bab42","volume":"23","author":"A Pestronk","year":"2011","unstructured":"Pestronk A (2011) Acquired immune and inflammatory myopathies: pathologic classification. Curr Opin Rheumatol 23(6):595\u2013604","journal-title":"Curr Opin Rheumatol"},{"issue":"3","key":"1384_CR76","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1002\/ana.23822","volume":"73","author":"H Pluk","year":"2013","unstructured":"Pluk H, van Hoeve BJA, van Dooren SHJ et al (2013) Autoantibodies to cytosolic 5\u2032-nucleotidase 1A in inclusion body myositis. Ann Neurol 73(3):397\u2013407","journal-title":"Ann Neurol"},{"issue":"1","key":"1384_CR77","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1002\/ana.410390122","volume":"39","author":"JN Pruitt","year":"1996","unstructured":"Pruitt JN, Showalter CJ, Engel AG (1996) Sporadic inclusion body myositis: counts of different types of abnormal fibers. Ann Neurol 39(1):139\u2013143","journal-title":"Ann Neurol"},{"issue":"10","key":"1384_CR78","doi-asserted-by":"crossref","first-page":"e46709","DOI":"10.1371\/journal.pone.0046709","volume":"7","author":"A Ray","year":"2012","unstructured":"Ray A, Amato AA, Bradshaw EM et al (2012) Autoantibodies produced at the site of tissue damage provide evidence of humoral autoimmunity in inclusion body myositis. PLoS One 7(10):e46709","journal-title":"PLoS One"},{"issue":"1","key":"1384_CR79","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1002\/ana.410370107","volume":"37","author":"Z Rifai","year":"1995","unstructured":"Rifai Z, Welle S, Kamp C, Thornton CA (1995) Ragged red fibers in normal aging and inflammatory myopathy. Ann Neurol 37(1):24\u201329","journal-title":"Ann Neurol"},{"issue":"1\u20132","key":"1384_CR80","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.jneuroim.2012.04.007","volume":"249","author":"A Rojana-Udomsart","year":"2012","unstructured":"Rojana-Udomsart A, Bundell C, James I, Castley A, Martinez P, Christiansen F, Hollingsworth P, Mastaglia F (2012) Frequency of autoantibodies and correlation with HLA-DRB1 genotype in sporadic inclusion body myositis (s-IBM): a population control study. J Neuroimmunol 249(1\u20132):66\u201370","journal-title":"J Neuroimmunol"},{"key":"1384_CR81","author":"A Rojana-Udomsart","year":"2012","unstructured":"Rojana-Udomsart A, James I, Castley A et al (2012) High-resolution HLA-DRB1 genotyping in an Australian inclusion body myositis (s-IBM) cohort: an analysis of disease-associated alleles and diplotypes. J Neuroimmunol. doi: 10.1016\/j.jneuroim.2012.05.003","journal-title":"J Neuroimmunol"},{"issue":"12","key":"1384_CR82","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/j.nmd.2013.08.007","volume":"23","author":"Rose MR, ENMC IBM Working Group","year":"2013","unstructured":"Rose MR, ENMC IBM Working Group (2013) 188th ENMC International Workshop: Inclusion Body Myositis, 2\u20134 December 2011, Naarden, The Netherlands. Neuromuscul Disord NMD 23(12):1044\u20131055","journal-title":"Neuromuscul Disord NMD"},{"key":"1384_CR83","doi-asserted-by":"crossref","unstructured":"Rose MR (2013) ENMC IBM Working Group 188th ENMC International Workshop: Inclusion Body Myositis, 2\u20134 December 2011, Naarden, The Netherlands. Neuromuscul Disord (in press)","DOI":"10.1016\/j.nmd.2013.08.007"},{"issue":"7","key":"1384_CR84","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1212\/WNL.58.7.1081","volume":"58","author":"SB Rutkove","year":"2002","unstructured":"Rutkove SB, Parker RA, Nardin RA, Connolly CE, Felice KJ, Raynor EM (2002) A pilot randomized trial of oxandrolone in inclusion body myositis. Neurology 58(7):1081\u20131087","journal-title":"Neurology"},{"key":"1384_CR85","author":"KA Rygiel","year":"2014","unstructured":"Rygiel KA, Miller J, Grady JP, Rocha MC, Taylor RW, Turnbull DM (2014) Mitochondrial and inflammatory changes in sporadic inclusion body myositis. Neuropathol Appl Neurobiol. doi: 10.1111\/nan.12149","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"5","key":"1384_CR86","doi-asserted-by":"crossref","first-page":"e20266","DOI":"10.1371\/journal.pone.0020266","volume":"6","author":"M Salajegheh","year":"2011","unstructured":"Salajegheh M, Lam T, Greenberg SA (2011) Autoantibodies against a 43\u00a0kDa muscle protein in inclusion body myositis. PLoS One 6(5):e20266","journal-title":"PLoS One"},{"issue":"1","key":"1384_CR87","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/mus.21386","volume":"40","author":"M Salajegheh","year":"2009","unstructured":"Salajegheh M, Pinkus JL, Taylor JP, Amato AA, Nazareno R, Baloh RH, Greenberg SA (2009) Sarcoplasmic redistribution of nuclear TDP-43 in inclusion body myositis. Muscle Nerve 40(1):19\u201331","journal-title":"Muscle Nerve"},{"issue":"Pt 23","key":"1384_CR88","doi-asserted-by":"crossref","first-page":"5325","DOI":"10.1242\/jcs.114041","volume":"126","author":"M Sandri","year":"2013","unstructured":"Sandri M, Coletto L, Grumati P, Bonaldo P (2013) Misregulation of autophagy and protein degradation systems in myopathies and muscular dystrophies. J Cell Sci 126(Pt 23):5325\u20135333","journal-title":"J Cell Sci"},{"key":"1384_CR89","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.yjmcc.2013.12.015","volume":"71","author":"M Sandri","year":"2014","unstructured":"Sandri M, Robbins J (2014) Proteotoxicity: an underappreciated pathology in cardiac disease. J Mol Cell Cardiol 71:3\u201310","journal-title":"J Mol Cell Cardiol"},{"issue":"Pt 5","key":"1384_CR90","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1093\/brain\/awn053","volume":"131","author":"J Schmidt","year":"2008","unstructured":"Schmidt J, Barthel K, Wrede A, Salajegheh M, Bahr M, Dalakas MC (2008) Interrelation of inflammation and APP in sIBM: IL-1 beta induces accumulation of beta-amyloid in skeletal muscle. Brain 131(Pt 5):1228\u20131240","journal-title":"Brain"},{"issue":"Pt 4","key":"1384_CR91","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1093\/brain\/aws046","volume":"135","author":"J Schmidt","year":"2012","unstructured":"Schmidt J, Barthel K, Zschuntzsch J et al (2012) Nitric oxide stress in sporadic inclusion body myositis muscle fibres: inhibition of inducible nitric oxide synthase prevents interleukin-1beta-induced accumulation of beta-amyloid and cell death. Brain 135(Pt 4):1102\u20131114","journal-title":"Brain"},{"issue":"11","key":"1384_CR92","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1586\/1744666X.2013.842467","volume":"9","author":"J Schmidt","year":"2013","unstructured":"Schmidt J, Dalakas MC (2013) Inclusion body myositis: from immunopathology and degenerative mechanisms to treatment perspectives. Expert Rev Clin Immunol 9(11):1125\u20131133","journal-title":"Expert Rev Clin Immunol"},{"issue":"Pt 5","key":"1384_CR93","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1093\/brain\/awh148","volume":"127","author":"J Schmidt","year":"2004","unstructured":"Schmidt J, Rakocevic G, Raju R, Dalakas MC (2004) Upregulated inducible co-stimulator (ICOS) and ICOS-ligand in inclusion body myositis muscle: significance for CD8+ T cell cytotoxicity. Brain 127(Pt 5):1182\u20131190","journal-title":"Brain"},{"issue":"7","key":"1384_CR94","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1002\/art.1780310707","volume":"31","author":"JL Sen\u00e9cal","year":"1988","unstructured":"Sen\u00e9cal JL, Rauch J (1988) Hybridoma lupus autoantibodies can bind major cytoskeletal filaments in the absence of DNA-binding activity. Arthritis Rheum 31(7):864\u2013875","journal-title":"Arthritis Rheum"},{"issue":"6","key":"1384_CR95","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1002\/pmic.201300334","volume":"14","author":"C Solier","year":"2014","unstructured":"Solier C, Langen H (2014) Antibody-based proteomics and biomarker research\u2014current status and limitations. Proteomics 14(6):774\u2013783","journal-title":"Proteomics"},{"issue":"4","key":"1384_CR96","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1097\/01.md.0000173991.74008.b0","volume":"84","author":"Y Troyanov","year":"2005","unstructured":"Troyanov Y, Targoff IN, Tremblay JL, Goulet JR, Raymond Y, Senecal JL (2005) Novel classification of idiopathic inflammatory myopathies based on overlap syndrome features and autoantibodies: analysis of 100 French Canadian patients. Med Baltim 84(4):231\u2013249","journal-title":"Med Baltim"},{"issue":"3","key":"1384_CR97","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/0090-1229(90)90058-X","volume":"54","author":"D Varon","year":"1990","unstructured":"Varon D, Linder S, Gembom E, Guedg L, Langbeheim H, Berrebi A, Eshhar Z (1990) Human monoclonal antibody derived from an autoimmune thrombocytopenic purpura patient, recognizing an intermediate filament\u2019s determinant common to vimentin and desmin. Clin Immunol Immunopathol 54(3):454\u2013468","journal-title":"Clin Immunol Immunopathol"},{"issue":"7","key":"1384_CR98","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1084\/jem.20031579","volume":"199","author":"V Viglietta","year":"2004","unstructured":"Viglietta V, Baecher-Allan C, Weiner HL, Hafler DA (2004) Loss of functional suppression by CD4+CD25+ regulatory T cells in patients with multiple sclerosis. J Exp Med 199(7):971\u2013979","journal-title":"J Exp Med"},{"key":"1384_CR99","author":"M Vyver Van de","year":"2014","unstructured":"Van de Vyver M, Myburgh KH (2014) Variable inflammation and intramuscular STAT3 phosphorylation and myeloperoxidase levels after downhill running. Scand J Med Sci Sports. doi: 10.1111\/sms.12164","journal-title":"Scand J Med Sci Sports"},{"issue":"1","key":"1384_CR100","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1007\/s004150050005","volume":"247","author":"MC Walter","year":"2000","unstructured":"Walter MC, Lochmuller H, Toepfer M, Schlotter B, Reilich P, Schroder M, Muller-Felber W, Pongratz D (2000) High-dose immunoglobulin therapy in sporadic inclusion body myositis: a double-blind, placebo-controlled study. J Neurol 247(1):22\u201328","journal-title":"J Neurol"},{"issue":"10","key":"1384_CR101","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1136\/jnnp.2007.131334","volume":"79","author":"CC Weihl","year":"2008","unstructured":"Weihl CC, Temiz P, Miller SE, Watts G, Smith C, Forman M, Hanson PI, Kimonis V, Pestronk A (2008) TDP-43 accumulation in inclusion body myopathy muscle suggests a common pathogenic mechanism with frontotemporal dementia. J Neurol Neurosurg Psychiatry 79(10):1186\u20131189","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"13","key":"1384_CR102","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1096\/fj.03-0039fje","volume":"17","author":"H Wiendl","year":"2003","unstructured":"Wiendl H, Mitsdoerffer M, Schneider D, Chen L, Lochmuller H, Melms A, Weller M (2003) Human muscle cells express a B7-related molecule, B7-H1, with strong negative immune regulatory potential: a novel mechanism of counterbalancing the immune attack in idiopathic inflammatory myopathies. FASEB J 17(13):1892\u20131894","journal-title":"FASEB J"},{"issue":"8","key":"1384_CR103","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1136\/jmg.39.8.537","volume":"39","author":"RS Wildin","year":"2002","unstructured":"Wildin RS, Smyk-Pearson S, Filipovich AH (2002) Clinical and molecular features of the immunodysregulation, polyendocrinopathy, enteropathy, X linked (IPEX) syndrome. J Med Genet 39(8):537\u2013545","journal-title":"J Med Genet"},{"issue":"3\u20134","key":"1384_CR104","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S1359-6101(03)00019-4","volume":"14","author":"SR Wiley","year":"2003","unstructured":"Wiley SR, Winkles JA (2003) TWEAK, a member of the TNF superfamily, is a multifunctional cytokine that binds the TweakR\/Fn14 receptor. Cytokine Growth Factor Rev 14(3\u20134):241\u2013249","journal-title":"Cytokine Growth Factor Rev"},{"issue":"Pt 10","key":"1384_CR105","doi-asserted-by":"crossref","first-page":"2670","DOI":"10.1093\/brain\/awu210","volume":"137","author":"T Yonekawa","year":"2014","unstructured":"Yonekawa T, Malicdan MCV, Cho A, Hayashi YK, Nonaka I, Mine T, Yamamoto T, Nishino I, Noguchi S (2014) Sialyllactose ameliorates myopathic phenotypes in symptomatic GNE myopathy model mice. Brain J Neurol 137(Pt 10):2670\u20132679","journal-title":"Brain J Neurol"},{"issue":"12","key":"1384_CR106","doi-asserted-by":"crossref","first-page":"4094","DOI":"10.1002\/art.37692","volume":"64","author":"J Zsch\u00fcntzsch","year":"2012","unstructured":"Zsch\u00fcntzsch J, Voss J, Creus K, Sehmisch S, Raju R, Dalakas MC, Schmidt J (2012) Provision of an explanation for the inefficacy of immunotherapy in sporadic inclusion body myositis: quantitative assessment of inflammation and \u03b2-amyloid in the muscle. Arthritis Rheum 64(12):4094\u20134103","journal-title":"Arthritis Rheum"}],"container-title":["Acta Neuropathologica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00401-015-1384-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00401-015-1384-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00401-015-1384-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,16]],"date-time":"2025-05-16T17:57:37Z","timestamp":1747418257000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00401-015-1384-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1,13]]},"references-count":106,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,5]]}},"alternative-id":["1384"],"URL":"https:\/\/doi.org\/10.1007\/s00401-015-1384-5","relation":{},"ISSN":["0001-6322","1432-0533"],"issn-type":[{"value":"0001-6322","type":"print"},{"value":"1432-0533","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,1,13]]}}}